The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
about
Prevention of vertical transmission of HIV-1 in resource-limited settingsAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionAntiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionVaginal disinfection for preventing mother-to-child transmission of HIV infectionEfficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1Vertical transmission of the hepatitis C virus: Current knowledge and issuesManagement of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential PracticesThe implications of HIV for the anaesthetist and the intensivist.Factors associated with HIV infection among children born to mothers on the prevention of mother to child transmission programme at Chitungwiza Hospital, Zimbabwe, 2008.The potential anesthetic threats, challenges and intensive care considerations in patients with HIV infection.Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data.Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.Accelerated publication versus usual publication in 2 leading medical journalsCost effectiveness analysis of antenatal HIV screening in United Kingdom.Timing and determinants of mother-to-child transmission of HIV in Nigeria.Recent advances: Paediatrics.Regular review: HIV infection in childrenRecent advances: obstetricsElective cesarean section for women living with HIV: a systematic review of risks and benefitsEffects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South AfricaInterventions aimed at decreasing the risk of mother-to-child transmission of HIV infection.Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India.Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.Current treatment options to prevent perinatal transmission of HIV.Antenatal screening for HIV: time to embrace change.Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected womenA retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South AThe urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome.Understanding HIV/AIDS: Psychosocial and Psychiatric Issues in Youths.Factors associated with willingness to participate in free HIV test among general residents in Heilongjiang, Northeast ChinaMode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.Vaginal disinfection during labour for reducing the risk of mother-to-child transmission of HIV infection.The role of cell-associated virus in mother-to-child HIV transmission.Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.Perinatal HIV transmission: developing country considerations.
P2860
Q22241479-5E0B86AD-F58C-49F9-947A-723E4D01CDD2Q24235500-7151D20C-562A-44D3-B414-DB7A0D70B46EQ24236763-D73DE924-4F1D-40B3-8DEE-62469D5B34A3Q24243146-F167212C-B6AC-4DFC-B3EE-C1279F2F37B9Q24245463-376B92FB-CE2F-4EBD-B85B-467871D2611AQ24245845-0B2B9CF5-F6A6-4F59-86C6-F38DCA04AE6BQ24652942-06FF41FC-7BDA-4DC0-8A4E-F79278B40959Q26738453-95F8A138-38F3-4910-9741-40D87F0A063FQ30326734-224D10EC-EF14-4CC1-B343-A612A446D13EQ30356701-F3BC8CF8-69F0-4FA7-85F3-D74763CA95EDQ30429050-7F1E7EEF-17F9-49BC-AD8F-64CEC0DF5A86Q30583689-13C99092-0E98-4C7A-AB67-029521B568E3Q31033395-5AEDC252-8A93-46F6-8A56-765073CCD5D4Q33396762-814D074D-DA80-4436-B81B-FCAEFB17D37EQ33427616-31B6564E-359C-4BEE-94DA-B9BFA5AB8498Q33559823-E596A079-9AB9-4DA6-9231-AD2E2A7F9C8BQ33609417-44297EAE-42B2-4EA3-A9C1-673D58E007ACQ33681734-49621640-9316-42B7-8359-9C69D1503503Q33769871-76889327-687C-48DC-ABBC-A5D358486D8FQ33805905-39C9DE45-FBFE-4ABD-80E6-1EE1DBABC129Q33807209-CD290E20-693E-45A4-9A19-D00BBDE8E083Q33817783-CDEC910B-3620-40DA-B18D-92B9FDF6A87AQ33853684-A36E792D-0403-4E84-ABC5-2014959065C6Q33893057-ABF2BF65-4405-46F5-8942-D585E1E40B15Q33906773-C07BF137-350F-438A-8335-D04EE62E593CQ33924110-48291D2A-E492-4386-8B9B-1E92B98B370EQ33983697-54CCEA8C-204D-437A-9971-A5F7F94BCB15Q34182238-C397FB6F-A0A2-4477-B41B-DB347B36EE56Q34190921-9CDB2C7F-8EC5-4334-B8DA-D3B7C4C9D4E7Q34240876-D44E43A6-F202-4711-89D1-DDDFBB8756FBQ34410400-4AE15BA7-2485-4B11-A45F-2773ECCC1BDDQ34419035-9C4CE741-7878-45B5-95F8-A337FF158740Q34424528-F7047F57-259C-4703-B198-78535CC9F3B8Q34443378-FBC7BD03-6790-4AFB-A63E-C4C9421A61E2Q34615517-0D3D20F5-8B27-4CEA-AA10-94B385F0CC44Q34758315-AE00CED7-6A56-4422-8953-24035AFA6D08Q35000080-E50327D8-33EF-40D4-80E3-44EB1C9D78E0Q35000633-F2E2EAFD-D343-4A2A-A28E-D730EC8FC534Q35015853-86C3E5DC-8CA7-4776-8333-9372D1725338Q35046412-3A7C2734-D5E7-4FE7-8D91-641451B89250
P2860
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The mode of delivery and the r ...... 15 prospective cohort studies.
@ast
The mode of delivery and the r ...... 15 prospective cohort studies.
@en
The mode of delivery and the r ...... 15 prospective cohort studies.
@nl
type
label
The mode of delivery and the r ...... 15 prospective cohort studies.
@ast
The mode of delivery and the r ...... 15 prospective cohort studies.
@en
The mode of delivery and the r ...... 15 prospective cohort studies.
@nl
prefLabel
The mode of delivery and the r ...... 15 prospective cohort studies.
@ast
The mode of delivery and the r ...... 15 prospective cohort studies.
@en
The mode of delivery and the r ...... 15 prospective cohort studies.
@nl
P2093
P1476
The mode of delivery and the r ...... 15 prospective cohort studies.
@en
P2093
A Semprini
International Perinatal HIV Group
L Mandelbrot
P304
P356
10.1056/NEJM199904013401301
P407
P50
P577
1999-04-01T00:00:00Z